GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (LSE:TCF) » Definitions » Price-to-Funds-From-Operations

TheraCryf (LSE:TCF) Price-to-Funds-From-Operations : (As of Apr. 11, 2025)


View and export this data going back to 2015. Start your Free Trial

What is TheraCryf Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


TheraCryf Business Description

Industry
Traded in Other Exchanges
N/A
Address
Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
TheraCryf PLC is a clinical-stage biotechnology company focused on profitable segments in oncology and neuropsychiatry. The company's lead clinical asset, SFX-01 is a patented form of delivering sulforaphane, which could be used in the treatment of a number of cancers, neurodevelopmental disorders, and other diseases.